HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 TFA also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 TFA can be uesd for breast cancer research[1].
Molecular Weight:
613.46
Purity:
99.48
Formula:
C28H29Cl2F3N4O4
Target:
CDK,DYRK,GSK-3,MELK,mTOR,Pim,RIP kinase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
